| Novartis Pharma Schweiz AG - Jakavi 5 mg, Tabletten | | 62126 | | 01 | | Jakavi 5 mg | | Tabletten | | L01EJ01 | | | | 27.12.2012 | | |
| | Composition | | ruxolitinibum 5 mg ut ruxolitinibi phosphas, lactosum monohydricum 71.45 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, hydroxypropylcellulosum, povidonum K 30, silica colloidalis anhydrica, magnesii stearas, pro compresso corresp. natrium 0.32 mg. | | Packungsbestandteile | | Tablets | | | | | | BAG: Active Agent | Dose |
|---|
| | 5 mg |
| | | | Inactive agents | Dose |
|---|
| | | | | | | | | | Lactose Monohydrate | 71.45 mg | | | | | | 30 | | | | | Silica Colloidalis Anhydrica | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 56 Tablet(s) | 1584.82 | 1740.00 | A | SL | No | | 002 | 3 x 56 Tablet(s) | PR | PR | A | | Yes |
|
|
